Glenmark launches sacubitril+valsartan tablets in India to treat heart failure
The launch of the tablets under the brand name, Sacu V, brings down the cost of treatment for heart failure
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
heart failure treatment
CDSCO approves AstraZeneca’s Dapagliflozin with additional indication for treating CKD and heart…
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalisation for heart failure in adults with…
CDSCO approves Boehringer Ingelheim’s Jardiance for treating heart failure
It's the first treatment for heart failure with preserved ejection fraction (HFpEF) in India
SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData
Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…